NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 01 12:46PM ET
66.03
Dollar change
+0.87
Percentage change
1.34
%
IndexS&P 500 P/E27.88 EPS (ttm)2.37 Insider Own0.90% Shs Outstand222.84M Perf Week1.86%
Market Cap14.72B Forward P/E14.66 EPS next Y4.51 Insider Trans0.27% Shs Float220.85M Perf Month6.22%
Enterprise Value15.63B PEG4.06 EPS next Q1.05 Inst Own102.08% Short Float2.28% Perf Quarter6.90%
Income556.70M P/S3.65 EPS this Y2.51% Inst Trans-2.26% Short Ratio1.38 Perf Half Y-9.19%
Sales4.03B P/B3.19 EPS next Y7.73% ROA6.45% Short Interest5.03M Perf YTD-8.40%
Book/sh20.73 P/C9.08 EPS next 5Y6.86% ROE11.77% 52W High84.67 -22.01% Perf Year-11.02%
Cash/sh7.27 P/FCF14.78 EPS past 3/5Y-22.74% - ROIC7.85% 52W Low51.90 27.23% Perf 3Y-6.90%
Dividend Est.- EV/EBITDA12.48 Sales past 3/5Y-10.56% 3.66% Gross Margin55.98% Volatility2.06% 2.06% Perf 5Y23.04%
Dividend TTM- EV/Sales3.88 EPS Y/Y TTM21.95% Oper. Margin23.72% ATR (14)1.55 Perf 10Y74.10%
Dividend Ex-Date- Quick Ratio2.52 Sales Y/Y TTM1.66% Profit Margin13.83% RSI (14)65.62 Recom2.50
Dividend Gr. 3/5Y- - Current Ratio3.24 EPS Q/Q-110.78% SMA202.39% Beta0.55 Target Price66.93
Payout0.00% Debt/Eq0.55 Sales Q/Q-1.23% SMA509.58% Rel Volume0.30 Prev Close65.16
Employees7063 LT Debt/Eq0.54 EarningsMay 01 AMC SMA200-4.40% Avg Volume3.64M Price66.03
IPOMar 01, 1990 Option/ShortYes / Yes EPS/Sales Surpr.1.37% 0.48% Trades Volume571,207 Change1.34%
Date Action Analyst Rating Change Price Target Change
May-27-25Reiterated Needham Hold
Mar-03-25Downgrade Argus Buy → Hold
Feb-06-25Downgrade Leerink Partners Outperform → Market Perform $80 → $75
Feb-03-25Downgrade Needham Buy → Hold
Dec-13-24Initiated Wolfe Research Peer Perform
Dec-10-24Reiterated Needham Buy $90
Dec-10-24Initiated Jefferies Hold $85
Oct-01-24Downgrade Citigroup Buy → Neutral $95 → $85
Jun-27-24Initiated Stephens Overweight $87
Apr-03-24Upgrade Citigroup Neutral → Buy $80 → $95
Jun-26-25 05:45PM
04:08AM
Jun-25-25 09:13AM
Jun-23-25 09:32AM
09:00AM
06:41AM Loading…
Jun-20-25 06:41AM
Jun-17-25 05:45PM
Jun-16-25 08:30AM
Jun-11-25 08:29AM
Jun-10-25 08:04PM
09:00AM
Jun-09-25 08:42AM
Jun-04-25 08:41AM
May-30-25 09:00AM
May-28-25 05:16PM
04:29AM Loading…
04:29AM
May-27-25 11:35PM
05:22PM
04:07PM
02:04PM
08:24AM
May-22-25 05:05PM
May-21-25 12:01AM
May-19-25 09:00AM
May-15-25 04:46PM
May-13-25 04:10PM
09:16AM
May-12-25 08:44AM
May-07-25 12:16PM
May-06-25 09:00AM
12:32AM Loading…
12:32AM
May-02-25 02:25PM
11:57AM
10:11AM
07:25AM
03:15AM
May-01-25 08:24PM
05:30PM
05:10PM
04:17PM
04:01PM
Apr-30-25 05:50PM
09:31AM
Apr-28-25 09:15AM
08:45AM
Apr-25-25 08:18AM
Apr-24-25 08:10AM
Apr-23-25 09:00AM
Apr-22-25 10:10AM
09:03AM
08:08AM
Apr-21-25 05:45PM
Apr-14-25 05:45PM
Apr-11-25 09:00AM
Apr-10-25 05:14AM
Apr-07-25 05:45PM
08:48AM
Apr-04-25 04:15PM
Apr-03-25 04:30PM
09:40AM
Mar-31-25 05:45PM
09:00AM
Mar-24-25 05:45PM
Mar-20-25 11:46AM
Mar-19-25 09:57AM
09:00AM
Mar-17-25 05:45PM
Mar-13-25 06:58PM
Mar-10-25 05:01AM
Mar-07-25 11:30AM
09:00AM
Mar-04-25 07:37AM
Feb-26-25 04:01AM
Feb-25-25 08:15AM
Feb-24-25 09:00AM
Feb-21-25 12:28PM
08:30AM
Feb-20-25 05:23AM
03:00AM
Feb-19-25 05:16AM
Feb-18-25 08:08AM
Feb-12-25 08:08AM
Feb-11-25 09:15AM
09:00AM
08:12AM
Feb-07-25 09:40AM
07:21AM
Feb-06-25 09:50AM
09:34AM
08:05AM
02:13AM
Feb-05-25 05:30PM
05:15PM
04:11PM
04:11PM
04:01PM
Feb-04-25 09:40AM
Jan-31-25 09:15AM
09:00AM
Jan-29-25 10:01AM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Madaus Martin DDirectorMay 07 '25Buy55.245,445300,7605,445May 09 04:39 PM
Mitchell Essex DChief Operating OfficerDec 04 '24Option Exercise62.6022,9021,433,65952,813Dec 06 04:28 PM
Mitchell Essex DChief Operating OfficerDec 04 '24Sale76.3424,8561,897,48227,957Dec 06 04:28 PM
Mitchell Essex DOfficerDec 04 '24Proposed Sale76.3424,8561,897,484Dec 04 12:24 PM
Oberton Karleen MarieChief Financial OfficerAug 29 '24Option Exercise40.9532,8051,343,214136,721Sep 03 04:15 PM
Oberton Karleen MarieChief Financial OfficerAug 29 '24Sale80.5652,6794,243,66284,042Sep 03 04:15 PM
Oberton Karleen MarieOfficerAug 29 '24Proposed Sale80.5652,6794,243,657Aug 29 04:36 PM
Schnittker BrandonDiv. President, GYN SurgicalAug 06 '24Sale83.1147639,5593,735Aug 08 04:08 PM
Schnittker BrandonOfficerAug 06 '24Proposed Sale83.1147639,559Aug 06 04:48 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 01 '24Sale81.995,093417,57010,476Aug 05 04:29 PM
MACMILLAN STEPHEN PChairman, President and CEOJul 30 '24Option Exercise26.2144,0391,154,2621,201,601Aug 01 04:09 PM
MACMILLAN STEPHEN PChairman, President and CEOJul 30 '24Sale81.7044,0393,597,9241,157,562Aug 01 04:09 PM
COHN BENJAMIN JORDANOfficerAug 01 '24Proposed Sale81.995,093417,574Aug 01 03:58 PM
MACMILLAN STEPHEN POfficerJul 30 '24Proposed Sale81.7044,0393,597,894Jul 30 04:29 PM
MACMILLAN STEPHEN PChairman, President and CEOJul 17 '24Option Exercise26.213,67296,2431,161,234Jul 19 04:09 PM
MACMILLAN STEPHEN PChairman, President and CEOJul 17 '24Sale80.133,672294,2231,157,562Jul 19 04:09 PM
Stamoulis ChristianaDirectorJul 17 '24Option Exercise26.749,039241,70354,511Jul 19 04:06 PM
Stamoulis ChristianaDirectorJul 17 '24Sale79.509,039718,60045,472Jul 19 04:06 PM